Davidson Capital Management’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.43M Buy
63,017
+6,333
+11% +$569K 0.9% 36
2026
Q2
$5.42M Buy
56,684
+1,662
+3% +$151K 0.87% 31
2026
Q1
$5.3M Buy
55,022
+54,895
+43,224% +$5.49M 0.96% 28
2025
Q4
$12.4K Buy
+127
New +$10.9K ﹤0.01% 72

Other funds holding IRMD

Davidson Capital Management's IRMD Position: Q3 2026 in Review

Davidson Capital Management increased its iRadimed (IRMD) stake by 11% in Q3 2026, buying an estimated $569K and bringing the position to 63,017 shares worth $5.43M. The position accounts for 0.9% of the portfolio, ranked #36.

Davidson Capital Management first reported a position in IRMD in Q4 2025 and has held it in 4 quarters since. 47 funds tracked by Wall St. Rank hold IRMD as of Q3 2026.

  • Davidson Capital Management held 63,017 shares of iRadimed worth $5.43M as of Q3 2026.
  • Davidson Capital Management bought 6,333 iRadimed shares in Q3 2026, an estimated $569K.
  • iRadimed made up 0.9% of Davidson Capital Management's portfolio in Q3 2026, its #36 holding.
  • Davidson Capital Management first reported a position in iRadimed in Q4 2025 and has held it in 4 quarters since.
  • 47 funds tracked by Wall St. Rank held iRadimed as of Q3 2026.

Based on Davidson Capital Management's 13F filing for Q3 2026, filed 15 Oct 2026.